Fig. 1From: The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional studyNumbers of axSpA patients, who were screened, included in the study and included in the analyses. Flow chart template modified from http://consort-statement.org. PROMS, patient-reported outcome measurements; F-calprotectin, fecal calprotectin; P-Calprotectin, plasma calprotectin. 1Did not fulfill the axSpA classification criteria, 2The Medical Outcomes Study SF-36 questionnaire is missingBack to article page